Discover
OACC
Oaktree Acquisition Corp. III Life Sciences
10.75
1 x 10.69
4 x 10.64
bid
ask
-
0.01
0.09%
3 @ 04:00 PM
10.78 +0.03 (0.28%)
| Ytd | 1.61% | |
| 1y | 1.70% |
10.75
day range
10.76
10.50
52 week range
10.80
| Open | 10.75 | Prev Close | 10.76 | Low | 10.75 | High | 10.76 | Mkt Cap | 264.26M |
| Vol | 228.99K | Avg Vol | 31.29K | EPS | 0.28 | P/E | 38.39 | Forward P/E | N/A |
| Beta | -0.01 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-01 | 50-d Avg | 10.76 | 200-d Avg | 10.68 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 261.96K | ||
| Selling, General and Administrative Expense | 261.96K | ||
| Operating Income | -261.96K | ||
| Net Income | 1.60M | ||
| Net Income Common Stock | 1.60M | ||
| Net Income Common Stock (USD) | 1.60M | ||
| Consolidated Income | 1.60M | ||
| Earnings per Basic Share | 0.07 | ||
| Earnings per Basic Share (USD) | 0.07 | ||
| Earnings per Diluted Share | 0.07 | ||
| Earning Before Interest & Taxes (EBIT) | 1.60M | ||
| Earning Before Interest & Taxes (USD) | 1.60M | ||
| Weighted Average Shares | 19.20M | ||
| Weighted Average Shares Diluted | 19.20M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.18M | ||
| Cash and Equivalents (USD) | 1.18M | ||
| Investments | 205.28M | ||
| Investments Non-Current | 205.28M | ||
| Current Assets | 1.26M | ||
| Total Assets | 206.54M | ||
| Debt Current | 11.82K | ||
| Total Debt | 11.82K | ||
| Current Liabilities | 1.73M | ||
| Total Liabilities | 8.75M | ||
| Accumulated Retained Earnings (Deficit) | -7.49M | ||
| Shareholders Equity | -7.49M | ||
| Shareholders Equity (USD) | -7.49M | ||
| Assets Non-Current | 205.28M | ||
| Total Debt (USD) | 11.82K | ||
| Liabilities Non-Current | 7.02M | ||
| Trade and Non-Trade Payables | 1.72M | ||
| Cash Flow | |||
| Net Cash Flow / Change in Cash & Cash Equivalents | -97.26K | ||
| Net Cash Flow from Operations | -97.26K | ||